Mon, November 8, 2021
Sun, November 7, 2021
Fri, November 5, 2021
Thu, November 4, 2021
Wed, November 3, 2021
Tue, November 2, 2021

Scott Fidel Maintained (AMED) at Hold with Increased Target to $185 on, Nov 4th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-185-on-nov-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Scott Fidel of Stephens & Co., Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $178 to $185 on, Nov 4th, 2021.

Scott has made no other calls on AMED in the last 4 months.



There are 8 other peers that have a rating on AMED. Out of the 8 peers that are also analyzing AMED, 2 agree with Scott's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Taylor of "Cowen & Co." Initiated at Hold and Held Target at $195 on, Friday, September 10th, 2021
  • Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $220 on, Thursday, August 5th, 2021


These are the ratings of the 6 analyists that currently disagree with Scott


  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $225 on, Wednesday, November 3rd, 2021
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $190 on, Wednesday, October 13th, 2021
  • Andrew Mok of "UBS" Initiated at Strong Sell and Held Target at $150 on, Friday, September 24th, 2021
  • A.J. Rice of "Credit Suisse" Maintained at Buy with Decreased Target to $250 on, Wednesday, August 11th, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $250 on, Tuesday, August 10th, 2021
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $235 on, Tuesday, August 10th, 2021

Publication Contributing Sources